BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 21742253)

  • 1. Comparison of antidepressant efficacy-related SNPs among Taiwanese and four populations in the HapMap database.
    Chi MH; Lee SY; Chang HH; Yang YK; Lin E; Chen PS
    J Formos Med Assoc; 2011 Jul; 110(7):478-82. PubMed ID: 21742253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder.
    Lin E; Chen PS; Chang HH; Gean PW; Tsai HC; Yang YK; Lu RB
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Oct; 33(7):1167-72. PubMed ID: 19560507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain derived neurotrophic factor gene polymorphism (Val66Met) and short-term antidepressant response in major depressive disorder.
    Chi MH; Chang HH; Lee SY; Lee IH; Gean PW; Yang YK; Lu RB; Chen PS
    J Affect Disord; 2010 Nov; 126(3):430-5. PubMed ID: 20674983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No impact of eight NTRK2 genetic polymorphisms on 6-month antidepressant efficacy in depressed patients.
    Deflesselle E; Verstuyft C; Petit AC; Hardy P; David DJ; Falissard B; Fève B; Rigal L; Becquemont L; Corruble E; Colle R
    Pharmacogenomics; 2017 Mar; 18(4):349-357. PubMed ID: 28244805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
    Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
    Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of interleukin-1 beta gene polymorphism and childhood maltreatment on antidepressant treatment].
    Chen Y; Zhang Z; Xu Z; Pu M; Geng L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):801-4. PubMed ID: 26663052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case study of the utility of the HapMap database for pharmacogenomic haplotype analysis in the Taiwanese population.
    Lin E; Hwang Y; Tzeng CM
    Mol Diagn Ther; 2006; 10(6):367-70. PubMed ID: 17154653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No influence of PTGS2 polymorphisms on response and remission to antidepressants in major depression.
    Serretti A; Chiesa A; Calati R; Massat I; Linotte S; Kasper S; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    Psychiatry Res; 2011 Jun; 188(1):166-9. PubMed ID: 21168919
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.
    Zhang C; Wu Z; Hong W; Wang Z; Peng D; Chen J; Yuan C; Yu S; Xu L; Fang Y
    J Affect Disord; 2014 Feb; 155():288-94. PubMed ID: 24321200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of APC and REEP5 gene polymorphisms with major depression disorder and treatment response to antidepressants in a Han Chinese population.
    Yang Z; Ma X; Wang Y; Wang J; Xiang B; Wu J; Deng W; Li M; Wang Q; Li T
    Gen Hosp Psychiatry; 2012; 34(5):571-7. PubMed ID: 22795047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association study of the interleukin-1 beta (C-511T) genetic polymorphism with major depressive disorder, associated symptomatology, and antidepressant response.
    Yu YW; Chen TJ; Hong CJ; Chen HM; Tsai SJ
    Neuropsychopharmacology; 2003 Jun; 28(6):1182-5. PubMed ID: 12700687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of genetic polymorphisms in the glutamatergic and GABAergic systems and their interactions with environmental stressors on antidepressant response.
    Pu M; Zhang Z; Xu Z; Shi Y; Geng L; Yuan Y; Zhang X; Reynolds GP
    Pharmacogenomics; 2013 Feb; 14(3):277-88. PubMed ID: 23394390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
    Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haplotype analysis of single nucleotide polymorphisms in the vascular endothelial growth factor (VEGFA) gene and antidepressant treatment response in major depressive disorder.
    Tsai SJ; Hong CJ; Liou YJ; Chen TJ; Chen ML; Hou SJ; Yen FC; Yu YW
    Psychiatry Res; 2009 Sep; 169(2):113-7. PubMed ID: 19700204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
    Schatzberg AF; DeBattista C; Lazzeroni LC; Etkin A; Murphy GM; Williams LM
    Am J Psychiatry; 2015 Aug; 172(8):751-9. PubMed ID: 25815420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Common genetic variations in human brain-specific tryptophan hydroxylase-2 and response to antidepressant treatment.
    Tzvetkov MV; Brockmöller J; Roots I; Kirchheiner J
    Pharmacogenet Genomics; 2008 Jun; 18(6):495-506. PubMed ID: 18496129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A brain-derived neurotrophic factor (BDNF) haplotype is associated with antidepressant treatment outcome in mood disorders.
    Gratacòs M; Soria V; Urretavizcaya M; González JR; Crespo JM; Bayés M; de Cid R; Menchón JM; Vallejo J; Estivill X
    Pharmacogenomics J; 2008 Apr; 8(2):101-12. PubMed ID: 17505499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Association of CHRNA4 gene polymorphisms with response to antidepressant among ethnic Han Chinese].
    Yu J; Dong Z; Yu T; Li X; Sun X
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2019 Dec; 36(12):1230-1234. PubMed ID: 31813155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine.
    Lin KM; Tsou HH; Tsai IJ; Hsiao MC; Hsiao CF; Liu CY; Shen WW; Tang HS; Fang CK; Wu CS; Lu SC; Kuo HW; Liu SC; Chan HW; Hsu YT; Tian JN; Liu YL
    Pharmacogenomics; 2010 Nov; 11(11):1535-43. PubMed ID: 21121774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Menopausal status could modulate the association between 5-HTTLPR and antidepressant efficacy in depressed women: a pilot study.
    Gressier F; Verstuyft C; Hardy P; Becquemont L; Corruble E
    Arch Womens Ment Health; 2014 Dec; 17(6):569-73. PubMed ID: 25257397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.